CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

1993 • 388 citations

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

1979 • 378 citations

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

1995 • 301 citations

Multiple myeloma treated with high dose intravenous melphalan

1987 • 251 citations

Combination chemotherapy for multiple myeloma

1972 • 213 citations

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

1989 • 204 citations

INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA

1989 • 198 citations

A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients

1988 • 163 citations

Autotransplants in multiple myeloma: what have we learned?

1996 • 157 citations

Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis

1992 • 143 citations

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1993 • 128 citations

Autotransplants in multiple myeloma: what have we learned?

1996 • 118 citations

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma

1993 • 108 citations

Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.

1995 • 97 citations

REAPPRAISAL OF PLATEAU PHASE IN MYELOMA

1980 • 94 citations

Myeloma protein kinetics following chemotherapy

1982 • 94 citations

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1993 • 87 citations

MULTIPLE MYELOMA. II. ANALYSIS OF CYCLOPHOSPHAMIDE THERAPY IN 165 PATIENTS.

1964 • 81 citations

A Controlled Trial of Urethane Treatment in Multiple Myeloma

1966 • 76 citations

Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors.

1993 • 73 citations

Multiple Myeloma

1964 • 64 citations

Impact of response to treatment on survival in multiple myeloma: results in a series of 243 patients

1994 • 58 citations

Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma

1998 • 49 citations

Autologous stem cell transplantation in multiple myeloma: Results of the european group for bone marrow transplantation

1996 • 47 citations

Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma

1997 • 39 citations

Reassessment of the relationship between M-protein decrement and survival in multiple myeloma

1989 • 30 citations

Current Issues in Cancer: Multiple myeloma

1994 • 30 citations

Plateau phase in multiple myeloma: an analysis of long‐term follow‐up of 432 patients

1996 • 29 citations

Original articles

1991 • 20 citations

Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma

1997 • 19 citations

No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone

1991 • 17 citations

Treatment of alkylating resistant multiple myeloma with vincristine, BCNU, doxorubicin and prednisone (VBAP)

1986 • 14 citations

Cited By (0)

No citing papers found in database